Showing results (301-310 of 3,369) with videos related to
Sort By:
Pageof 337
ESC Heart Failure|March 13, 2020
Non-invasive telemedical care in heart failure patients and stroke: post hoc analysis of TIM-HF and TIM-HF2 trialsSerdar Tütüncü, Marcus Honold, Kerstin Koehler, et al.ESC Heart Failure|January 7, 2020
Role of PCSK9 in the course of ejection fraction change after ST-segment elevation myocardial infarction: a pilot studyGema Miñana, Julio Núñez, Antoni Bayés-Genís, et al.ESC Heart Failure|April 3, 2020
Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetesIfy R Mordi, Aaron Tee, Colin N Palmer, et al.ESC Heart Failure|April 3, 2020
Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shockSaraschandra Vallabhajosyula, Aditi Shankar, Sri Harsha Patlolla, et al.ESC Heart Failure|April 4, 2020
Physical vs. multidimensional frailty in older adults with and without heart failureGianluca Testa, Francesco Curcio, Ilaria Liguori, et al.ESC Heart Failure|April 4, 2020
Hypocalcaemic cardiomyopathy: a description of two cases and a literature reviewMartin Válek, Lenka Roblová, Ivan Raška, et al.ESC Heart Failure|September 23, 2020
Takotsubo syndrome in the same heart before and after heart transplantationMasaki Tsuji, Eisuke Amiya, Chie Bujo, et al.ESC Heart Failure|September 23, 2020
Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCATBin Dong, Xin He, Ruicong Xue, et al.ESC Heart Failure|September 23, 2020
Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fractionKoichiro Matsumura, Wakana Teranaka, Hiroshi Matsumoto, et al.ESC Heart Failure|September 23, 2020
Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetesRafael de la Espriella, Antoni Bayés-Genís, Herminio Morillas, et al.Pageof 337